Tiziana Life Sciences

$2.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+4.00%) Today
-$0.00 (-0.19%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell TLSA and other stocks, options, and ETFs commission-free!

About TLSA

Tiziana Life Sciences plc American Depository Share, also called Tiziana Life Sciences, is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom. The listed name for TLSA is Tiziana Life Sciences plc American Depository Share.

CEO
Kunwar Shailubhai
Employees
10
Headquarters
London, Greater London
Founded
2013
Market Cap
253.00M
Price-Earnings Ratio
Dividend Yield
Average Volume
323.91K
High Today
$2.62
Low Today
$2.43
Open Price
$2.49
Volume
151.37K
52 Week High
$12.17
52 Week Low
$0.616

Collections

TLSA Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Estimated
per share
Actual
Expected Nov 16, Pre-Market

You May Also Like